NCT00704574
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Lund, Sweden
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,994 public trials
713 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01542489
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Bratislava, Slovakia
NCT01937598
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Diabeteszentrum Bad Lauterberg Bad Lauterberg im Harz, Germany
NCT00104182
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Birmingham, Alabama, United States
- Novo Nordisk Investigational Site Mesa, Arizona, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Anaheim, California, United States
NCT00968812
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Calera, Alabama, United States
- Gilbert, Arizona, United States
- Mesa, Arizona, United States
- Tucson, Arizona, United States
NCT01497600
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Chula Vista, California, United States
NCT01497561
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Graz, Germany
NCT00592527
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Kochi, Kerala, India
- Novo Nordisk Investigational Site Ahmedabad, India
- Novo Nordisk Investigational Site Chennai, India
- Novo Nordisk Investigational Site Chennai, India
Completed
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
NCT01455896
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Study Site Chandler, Arizona, United States
- Intarcia Therapeutics, Inc Hayward, California, United States
- Study Site Long Beach, California, United States
- Study Site Port Hueneme, California, United States
NCT00604396
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Arlon, Belgium
- Novo Nordisk Investigational Site Gilly, Belgium
- Novo Nordisk Investigational Site Huy, Belgium
- Novo Nordisk Investigational Site Jumet, Belgium